Citigroup’s Innovid Corp. CTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-83,854
Closed -$259K 6087
2024
Q4
$259K Buy
83,854
+6,181
+8% +$14.6K ﹤0.01% 4248
2024
Q3
$140K Buy
77,673
+53,845
+226% +$97.8K ﹤0.01% 4595
2024
Q2
$44.1K Sell
23,828
-227,418
-91% -$488K ﹤0.01% 4664
2024
Q1
$626K Buy
251,246
+74,523
+42% +$129K ﹤0.01% 3416
2023
Q4
$265K Buy
176,723
+162,488
+1,141% +$207K ﹤0.01% 3805
2023
Q3
$18.2K Buy
+14,235
New +$16.7K ﹤0.01% 4421
2023
Q1
Sell
-2,000
Closed -$3.42K 5936
2022
Q4
$3.42K Sell
2,000
-625
-24% -$1.69K ﹤0.01% 5113
2022
Q3
$7K Sell
2,625
-83
-3% -$236 ﹤0.01% 5138
2022
Q2
$4K Buy
+2,708
New +$11.6K ﹤0.01% 5727

Citigroup's CTV Position: Q1 2025 in Review

Citigroup sold out of Innovid Corp. (CTV) in Q1 2025, closing a stake of 83,854 shares — an estimated $259K sold.

Citigroup first reported a position in CTV in Q2 2022 and held it in 9 quarters. The position peaked at $626K in Q1 2024. 0 funds tracked by Wall St. Rank hold CTV as of Q1 2025.

  • Citigroup reported no remaining Innovid Corp. position as of Q1 2025 after selling out during the quarter.
  • Citigroup sold 83,854 Innovid Corp. shares in Q1 2025, an estimated $259K.
  • Citigroup first reported a position in Innovid Corp. in Q2 2022 and held it in 9 quarters.
  • Citigroup's Innovid Corp. position peaked at $626K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Innovid Corp. as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.